Authors:
MURPHY KC
COPPIN CML
KADER HEHA
NORRIS BD
WEIR LM
HUGI MR
OLIVOTTO IA
LEES AW
GRAYDON JE
BOWMAN DM
BOUCHARD F
MICKELSON WP
LEVINE MN
MCGREGOR M
OLWENY C
AYOUB J
ARMANN D
BALDWIN J
CLARKE HF
COUTURE J
DAVIDSON JSD
GRANT B
HARTRICK G
HICKS S
HISCOCK J
KAIZER L
KINDRAT P
KUUSK U
MCINTOSHBURGESS B
MILLER AS
SMART M
THEMAN TW
WOODLAND H
Citation: Kc. Murphy et al., FOLLOW-UP AFTER TREATMENT FOR BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 65-70
Citation: J. Clinch et al., ANALYSIS OF QUALITY-OF-LIFE DATA IN A CLINICAL-TRIAL OF THE PALLIATIVE TREATMENT OF AIDS-ASSOCIATED KAPOSIS-SARCOMA (KS) IN ZIMBABWE, Quality of life research, 6(7-8), 1997, pp. 70-70
Authors:
NABHOLTZ JM
KHOO K
MACKEY JR
SMYLIE M
ALTWEGIERI T
DUDGEON D
KELLER O
FOERSTER O
OLWENY C
SHORE T
SANSREGRET E
STILES E
DULUDE H
GALLANT G
BROWN B
Citation: Jm. Nabholtz et al., TAXOL(TM) (PACLITAXEL), EPIRUBICIN AND CYCLOPHOSPHAMIDE (TEC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC) - RESULTS OF A PHASE-I STUDY, Breast, 6(5), 1997, pp. 320-320
Authors:
NABHOLTZ JM
KHOO K
MACKEY JR
SMYLIE M
ALTWEIGERI T
DUDGEON D
KELLER O
FOERSTER O
OLWENY C
SHORE T
SANSREGRET E
STILES E
DULUDE H
GALLANT G
BROWN B
Citation: Jm. Nabholtz et al., TAXOL(TM) (PACLITAXEL), EPIRUBICIN AND CYCLOPHOSPHAMIDE (TEC) IN THE TREATMENT OF METASTATIC BREAST-CANCER (MBC) - RESULTS OF A PHASE-I STUDY, European journal of cancer, 33, 1997, pp. 678-678
Authors:
QUIRT I
COUTURE F
PICHETTE R
OLWENY C
WHITE D
KING M
SAWKA C
HUAN S
CLINCH J
LAU C
Citation: I. Quirt et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL, Blood, 88(10), 1996, pp. 1378-1378
Authors:
SOMOGYI AA
NATION RL
OLWENY C
TSIRGIOTIS P
VANCRUGTEN J
MILNE RW
CLEARY JF
DANZ C
BOCHNER F
Citation: Aa. Somogyi et al., PLASMA-CONCENTRATIONS AND RENAL CLEARANCE OF MORPHINE, MORPHINE-3-GLUCURONIDE AND MORPHINE-6-GLUCURONIDE IN CANCER-PATIENTS RECEIVING MORPHINE, Clinical pharmacokinetics, 24(5), 1993, pp. 413-420